Clinical response of pigment epithelial detachment associated with neovascular age-related macular degeneration in switching treatment from Ranibizumab to Aflibercept

被引：0
|
作者：
Pallavi Tyagi
Zain Juma
Yong Keen Hor
Neil W. Scott
Andreea Ionean
Cynthia Santiago
机构：
[1] Department of Ophthalmology,The school of medicine
[2] Aberdeen Royal infirmary,Medical Statistics Team
[3] University of Aberdeen,undefined
[4] University of Aberdeen,undefined
来源：
BMC Ophthalmology | / 18卷
关键词：
Aflibercept; Pigment epithelial detachment; Neovascular age related macular degeneration;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
  • [31] Non-responsiveness to intravitreal aflibercept treatment in neovascular age-related macular degeneration: implications of serous pigment epithelial detachment
    Norihiro Nagai
    Misa Suzuki
    Atsuro Uchida
    Toshihide Kurihara
    Mamoru Kamoshita
    Sakiko Minami
    Hajime Shinoda
    Kazuo Tsubota
    Yoko Ozawa
    Scientific Reports, 6
  • [32] Intravitreal ranibizumab for treatment of fibrovascular pigment epithelial detachment in age-related macular degeneration Reply
    Iordanous, Yiannis
    Sheidow, Tom G.
    CANADIAN JOURNAL OF OPHTHALMOLOGY-JOURNAL CANADIEN D OPHTALMOLOGIE, 2015, 50 (05): : 396 - 396
  • [33] Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
    Marquis, Liza-Marie
    Mantel, Irmela
    GRAEFES ARCHIVE FOR CLINICAL AND EXPERIMENTAL OPHTHALMOLOGY, 2020, 258 (08) : 1591 - 1596
  • [34] Beneficial switch from aflibercept to ranibizumab for the treatment of refractory neovascular age-related macular degeneration
    Liza-Marie Marquis
    Irmela Mantel
    Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 1591 - 1596
  • [35] Ranibizumab Treatment for Pigment Epithelial Detachment Secondary to Neovascular Age-Related Macular Degeneration Post Hoc Analysis of the HARBOR Study
    Sarraf, David
    London, Nikolas J. S.
    Khurana, Rahul N.
    Dugel, Pravin U.
    Gune, Shamika
    Hill, Lauren
    Tuomi, Lisa
    OPHTHALMOLOGY, 2016, 123 (10) : 2213 - 2224
  • [36] Comparison of outcomes after switching treatment from intravitreal bevacizumab or ranibizumab to aflibercept in neovascular age-related macular degeneration
    Venzara, Frank
    Mason, John
    Glover, Jay
    McGwin, Gerald
    Huisingh, Carrie
    Friedman, Duncan
    Feist, Richard
    Thomley, Martin
    Albert, Michael
    Price, Natalie
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2013, 54 (15)
  • [37] Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration
    Hikaru Ota
    Jun Takeuchi
    Yuyako Nakano
    Etsuyo Horiguchi
    Yosuke Taki
    Yasuki Ito
    Hiroko Terasaki
    Koji M. Nishiguchi
    Keiko Kataoka
    Japanese Journal of Ophthalmology, 2022, 66 : 278 - 284
  • [38] Switching from aflibercept to brolucizumab for the treatment of refractory neovascular age-related macular degeneration
    Ota, Hikaru
    Takeuchi, Jun
    Nakano, Yuyako
    Horiguchi, Etsuyo
    Taki, Yosuke
    Ito, Yasuki
    Terasaki, Hiroko
    Nishiguchi, Koji M.
    Kataoka, Keiko
    JAPANESE JOURNAL OF OPHTHALMOLOGY, 2022, 66 (03) : 278 - 284
  • [39] AFLIBERCEPT FOR THE TREATMENT OF NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Verner-Cole, E. A.
    Davis, S. J.
    Lauer, A. K.
    DRUGS OF TODAY, 2012, 48 (05) : 317 - 329
  • [40] RETINAL PIGMENT EPITHELIAL TEAR AFTER INTRAVITREAL RANIBIZUMAB TREATMENT FOR NEOVASCULAR AGE-RELATED MACULAR DEGENERATION
    Cho, Han Joo
    Kim, Hyoung Seok
    Yoo, Seul Gi
    Han, Jung Il
    Lew, Young Ju
    Cho, Sung Won
    Lee, Tae Gon
    Kim, Jong Woo
    RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2016, 36 (10): : 1851 - 1859
12345